Quetiapine Augmentation Versus Clomipramine Augmentation of Selective Serotonin Reuptake Inhibitors for Obsessive-compulsive Disorder Patients That do Not Respond to a SSRI Trial: a Randomized Open-trial.

Trial Profile

Quetiapine Augmentation Versus Clomipramine Augmentation of Selective Serotonin Reuptake Inhibitors for Obsessive-compulsive Disorder Patients That do Not Respond to a SSRI Trial: a Randomized Open-trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Oct 2017

At a glance

  • Drugs Quetiapine (Primary) ; Clomipramine
  • Indications Obsessive-compulsive disorders
  • Focus Therapeutic Use
  • Acronyms QCAT
  • Most Recent Events

    • 11 Dec 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 04 Feb 2008 Status changed from in progress to completed.
    • 13 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top